Glaukos (GKOS) Operating Income (2014 - 2026)
Glaukos' (GKOS) quarterly Operating Income came in at -$17.3 million in Q2 2026, up 23.9% year-over-year from -$13.9 million in Q2 2025, and up 13.04% quarter-over-quarter from -$19.9 million in Q1 2026.
Analysis
Glaukos (GKOS) Operating Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Operating Income for 13 consecutive years, with -$17.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Income rose 23.9% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$193.4 million, a 99.97% decrease from a year earlier, with the FY2025 full-year figure at -$199.6 million, down 63.12% from the prior year.
- Operating Income was -$17.3 million for Q2 2026 at Glaukos, up from -$19.9 million in the prior quarter.
- Over five years, Operating Income peaked at $9.8 million in Q1 2022 and troughed at -$139.9 million in Q4 2025.
- A 5-year average of -$31.7 million and a median of -$28.3 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income soared 182.95% in 2022 and slumped 436.94% in 2023, its largest moves.
- Over 5 years, Operating Income stood at -$33.7 million in 2022, then declined by 14.49% to -$38.6 million in 2023, then climbed by 25.78% to -$28.7 million in 2024, then slumped by 387.92% to -$139.9 million in 2025, then jumped by 87.65% to -$17.3 million in 2026.
- The last three Operating Income figures came in at -$17.3 million (Q2 2026), -$19.9 million (Q1 2026), and -$139.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Glaukos | 10.70 Bn | 10.59 Bn | 151.59 Mn | -17.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.27 Mn |
| Mar 31, 2026 | -19.86 Mn |
| Dec 31, 2025 | -139.87 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Jun 30, 2025 | -22.69 Mn |
| Mar 31, 2025 | -20.68 Mn |
| Dec 31, 2024 | -28.67 Mn |
| Sep 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -29.97 Mn |
| Mar 31, 2024 | -39.07 Mn |
| Dec 31, 2023 | -38.62 Mn |
| Sep 30, 2023 | -28.01 Mn |
| Jun 30, 2023 | -29.08 Mn |
| Mar 31, 2023 | -32.99 Mn |
| Dec 31, 2022 | -33.73 Mn |
| Sep 30, 2022 | -21.61 Mn |
| Jun 30, 2022 | -36.76 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | -17.87 Mn |
| Sep 30, 2021 | 11.02 Mn |